Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Daiichi Sankyo
Mayo Clinic
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Jules Bordet Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)